174 related articles for article (PubMed ID: 38861221)
21. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of paraproteinaemic demyelinating neuropathies: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
; ; Hadden RD; Nobile-Orazio E; Sommer C; Hahn A; Illa I; Morra E; Pollard J; Hughes RA; Bouche P; Cornblath D; Evers E; Koski CL; Léger JM; Van den Bergh P; van Doorn P; van Schaik IN
Eur J Neurol; 2006 Aug; 13(8):809-18. PubMed ID: 16879290
[TBL] [Abstract][Full Text] [Related]
22. Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis.
Lin X; Yarlas A; Vera-Llonch M; Baranwal N; Biber J; Brown D; Vogt B; Karam C
BMC Neurol; 2021 Feb; 21(1):70. PubMed ID: 33579211
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal gammopathy and neuropathy.
Ramchandren S; Lewis RA
Curr Opin Neurol; 2009 Oct; 22(5):480-5. PubMed ID: 19625962
[TBL] [Abstract][Full Text] [Related]
24. Neuropathy and paraproteins: review of a complex association.
Rajabally YA
Eur J Neurol; 2011 Nov; 18(11):1291-8. PubMed ID: 21418441
[TBL] [Abstract][Full Text] [Related]
25. Paraproteinemic neuropathies.
Mauermann ML
Continuum (Minneap Minn); 2014 Oct; 20(5 Peripheral Nervous System Disorders):1307-22. PubMed ID: 25299284
[TBL] [Abstract][Full Text] [Related]
26. Peripheral neuropathy as clinical onset of monoclonal IgM/k-related amyloidosis.
Briani C; Ferrari S; Berno T; Visentin A; Cacciavillani M; Cavallaro T; Fedrigo M; Rizzo S; Salvalaggio A; Trentin L; Piazza F
J Peripher Nerv Syst; 2023 Jun; 28(2):262-265. PubMed ID: 36859783
[TBL] [Abstract][Full Text] [Related]
27. Advances in the Treatment of Paraproteinemic Neuropathy.
Nobile-Orazio E; Bianco M; Nozza A
Curr Treat Options Neurol; 2017 Oct; 19(12):43. PubMed ID: 29034435
[TBL] [Abstract][Full Text] [Related]
28. Cranial neurolymphomatosis and its oncologic counterparts: Case series on malignant cranial nerve neuropathies.
Srichawla BS; Bose A; Kipkorir V
SAGE Open Med Case Rep; 2024; 12():2050313X231221466. PubMed ID: 38162422
[TBL] [Abstract][Full Text] [Related]
29. Paraproteinaemic neuropathy: MGUS and beyond.
Carroll AS; Lunn MPT
Pract Neurol; 2021 Dec; 21(6):492-503. PubMed ID: 34282034
[TBL] [Abstract][Full Text] [Related]
30. Pro-inflammatory cytokines and leukocyte integrins associated with chronic neuropathic pain in traumatic and inflammatory neuropathies: Initial observations and hypotheses.
Dong C; Ubogu EE
Front Immunol; 2022; 13():935306. PubMed ID: 35983047
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological features of neuropathy associated with lymphoma.
Tomita M; Koike H; Kawagashira Y; Iijima M; Adachi H; Taguchi J; Abe T; Sako K; Tsuji Y; Nakagawa M; Kanda F; Takeda F; Sugawara M; Toyoshima I; Asano N; Sobue G
Brain; 2013 Aug; 136(Pt 8):2563-78. PubMed ID: 23884813
[TBL] [Abstract][Full Text] [Related]
32. Peripheral neuropathy in patients with benign monoclonal gammopathy--a pilot study.
Noring L; Osby E; Hast R; Kjellin KG; Knutsson E; Sidén A
J Neurol; 1982; 228(3):185-94. PubMed ID: 6186792
[TBL] [Abstract][Full Text] [Related]
33. Lymphoma and peripheral neuropathy: a clinical review.
Kelly JJ; Karcher DS
Muscle Nerve; 2005 Mar; 31(3):301-13. PubMed ID: 15543550
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies.
Latov N
Ann Neurol; 1995 May; 37 Suppl 1():S32-42. PubMed ID: 8968215
[TBL] [Abstract][Full Text] [Related]
35. POEMS syndrome: clinical update.
Brown R; Ginsberg L
J Neurol; 2019 Jan; 266(1):268-277. PubMed ID: 30498913
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of Nerve Damage in Neuropathies Associated with Hematological Diseases: Lesson from Nerve Biopsies.
Briani C; Ferrari S; Campagnolo M; Tagliapietra M; Castellani F; Salvalaggio A; Mariotto S; Visentin A; Cavallaro T
Brain Sci; 2021 Jan; 11(2):. PubMed ID: 33498362
[TBL] [Abstract][Full Text] [Related]
37. Clinical spectrum of Castleman disease-associated neuropathy.
Naddaf E; Dispenzieri A; Mandrekar J; Mauermann ML
Neurology; 2016 Dec; 87(23):2457-2462. PubMed ID: 27807187
[TBL] [Abstract][Full Text] [Related]
38. [Peripheral neuropathy with monoclonal gammopathy].
Meier T; Meyer M
Schweiz Med Wochenschr; 1990 Mar; 120(12):417-25. PubMed ID: 2157280
[TBL] [Abstract][Full Text] [Related]
39. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
Kelly JJ
Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
[TBL] [Abstract][Full Text] [Related]
40. Non-Hodgkin malignant lymphomas and peripheral neuropathies--13 cases.
Vallat JM; De Mascarel HA; Bordessoule D; Jauberteau MO; Tabaraud F; Gelot A; Vallat AV
Brain; 1995 Oct; 118 ( Pt 5)():1233-45. PubMed ID: 7496783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
